• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测马兜铃酸在中草药肾病患者肾组织中形成的DNA加合物。

Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.

作者信息

Schmeiser H H, Bieler C A, Wiessler M, van Ypersele de Strihou C, Cosyns J P

机构信息

Division of Molecular Toxicology, German Cancer Research Center, Heidelberg, Germany.

出版信息

Cancer Res. 1996 May 1;56(9):2025-8.

PMID:8616845
Abstract

A unique type of rapidly progressive renal fibrosis, designated Chinese herbs nephropathy (CHN), has been described in young Belgian women who had followed a slimming regimen including recently introduced Chinese herbs (Stephania tetrandra and Magnolia officinalis). Aristolochic acid (AA), a known nephrotoxin and carcinogen, was suspected as its causal factor. To substantiate this hypothesis, renal tissue from five patients with CHN and six patients with other renal diseases was analyzed for the presence of AA-derived DNA adducts, a described biomarker of AA exposure associated with its carcinogenic and mutagenic activity. Using the 32P-postlabeling method, a major distinct DNA adduct spot was found in all five cases of CHN and identified by cochromatographic analyses with authentic markers as the deoxyadenosine adduct of AA-I [7-(deoxyadenosin-N6-yl)-aristolactam I], the major component of the plant extract AA. This DNA adduct was absent in the six control cases. The 7-(deoxyadenosin-N6-yl)-aristolactam I adduct levels in CHN ranged from 0.7 to 5.3/10(7) nucleotides. Our data demonstrate that AA is implicated in CHN. They suggest a mechanism for the urothelial atypia and cancers observed in this disease and raise the possibility that a DNA mutation is responsible for the kidney-destructive fibrotic process.

摘要

一种独特的快速进展性肾纤维化,被称为中草药肾病(CHN),已在年轻的比利时女性中被描述,她们遵循了包括最近引入的中草药(防己和厚朴)的减肥方案。马兜铃酸(AA),一种已知的肾毒素和致癌物,被怀疑是其致病因素。为了证实这一假设,对5例CHN患者和6例其他肾脏疾病患者的肾组织进行了分析,以检测AA衍生的DNA加合物的存在,这是一种与AA的致癌和诱变活性相关的已描述的AA暴露生物标志物。使用32P后标记法,在所有5例CHN病例中均发现了一个主要的独特DNA加合物斑点,并通过与真实标记物的共色谱分析鉴定为AA-I [7-(脱氧腺苷-N6-基)-马兜铃内酰胺I]的脱氧腺苷加合物,这是植物提取物AA的主要成分。在6例对照病例中未发现这种DNA加合物。CHN中7-(脱氧腺苷-N6-基)-马兜铃内酰胺I加合物水平在0.7至5.3/10(7)个核苷酸之间。我们的数据表明AA与CHN有关。它们提示了在这种疾病中观察到的尿路上皮异型增生和癌症的一种机制,并增加了DNA突变是导致肾脏破坏性纤维化过程的原因的可能性。

相似文献

1
Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.检测马兜铃酸在中草药肾病患者肾组织中形成的DNA加合物。
Cancer Res. 1996 May 1;56(9):2025-8.
2
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.对服用含马兜铃酸的中药导致的中草药肾病患者组织中由马兜铃酸形成的DNA加合物进行32P后标记分析。
Carcinogenesis. 1997 May;18(5):1063-7. doi: 10.1093/carcin/18.5.1063.
3
Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.马兜铃酸 I 的代谢产物马兜铃内酰胺 I 经活化后形成一种加合物,在中草药肾病患者的 DNA 中可发现该加合物。
Exp Toxicol Pathol. 1999 Jul;51(4-5):421-7. doi: 10.1016/S0940-2993(99)80033-5.
4
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.致癌和肾毒性生物碱马兜铃酸在被NADPH:细胞色素P450还原酶激活后,会形成在中草药肾病患者DNA中发现的加合物。
Gen Physiol Biophys. 2001 Dec;20(4):375-92.
5
Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.对中草药肾病患者中由赭曲霉毒素A和马兜铃酸形成的DNA加合物的分析。
Mutat Res. 2001 Jul 25;494(1-2):143-50. doi: 10.1016/s1383-5718(01)00188-7.
6
Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.前列腺素H合酶对致癌马兜铃酸进行还原激活的证据——DNA加合物形成的(32)P后标记分析
Mutat Res. 2001 Jun 27;493(1-2):149-60. doi: 10.1016/s1383-5718(01)00171-1.
7
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.致癌的马兜铃酸经DT-黄递酶激活后形成加合物,这些加合物存在于中草药肾病患者的DNA中。
Carcinogenesis. 2002 Apr;23(4):617-25. doi: 10.1093/carcin/23.4.617.
8
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.马兜铃酸与“中草药肾病”:迄今证据综述
Drug Saf. 2003;26(1):33-48. doi: 10.2165/00002018-200326010-00004.
9
Urothelial lesions in Chinese-herb nephropathy.中草药肾病中的尿路上皮病变
Am J Kidney Dis. 1999 Jun;33(6):1011-7. doi: 10.1016/S0272-6386(99)70136-8.
10
Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?一名中国患者的马兜铃酸肾病:是时候摒弃“中草药肾病”这一术语了吗?
Am J Kidney Dis. 2001 Nov;38(5):E26. doi: 10.1053/ajkd.2001.28624.

引用本文的文献

1
Detection and Removal of Aristolochic Acid in Natural Plants, Pharmaceuticals, and Environmental and Biological Samples: A Review.天然植物、药物、环境和生物样本中马兜铃酸的检测与去除:综述。
Molecules. 2023 Dec 22;29(1):81. doi: 10.3390/molecules29010081.
2
Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.黄芩素 II,一种新型 NQO1 抑制剂,可减轻马兜铃酸 I 诱导的小鼠肝肾功能损伤。
Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441. doi: 10.1038/s41401-023-01052-3. Epub 2023 Jan 25.
3
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。
World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.
4
Aristolochic acid-associated cancers: a public health risk in need of global action.马兜铃酸相关癌症:亟待全球行动的公共健康风险。
Nat Rev Cancer. 2022 Oct;22(10):576-591. doi: 10.1038/s41568-022-00494-x. Epub 2022 Jul 19.
5
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers.马兜铃酸突变特征在口腔-胃肠道癌症中的罕见发生
Cancers (Basel). 2022 Jan 24;14(3):576. doi: 10.3390/cancers14030576.
6
A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2'-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients.一项DNA加合物组分析显示,尿路上皮癌患者非肿瘤性上尿路黏膜中C5-羟甲基-2'-脱氧胞苷的整体水平降低。
Genes Environ. 2021 Dec 2;43(1):52. doi: 10.1186/s41021-021-00228-9.
7
Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.马兜铃酸 I 和 II 的共同暴露会增加导致大鼠马兜铃酸 I 致癌性的 DNA 加合物的形成。
Int J Mol Sci. 2021 Sep 28;22(19):10479. doi: 10.3390/ijms221910479.
8
Acute and Subchronic Toxicity Studies of Aristolochic Acid A in Tianfu Broilers.马兜铃酸A对天府肉鸡的急性和亚慢性毒性研究
Animals (Basel). 2021 May 27;11(6):1556. doi: 10.3390/ani11061556.
9
Novel advances in biotransformation and bioactivation research - 2020 year in review.生物转化和生物活化研究的新进展——2020 年回顾。
Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24.
10
Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.采用体外和基于生理学的动力学建模方法,定义马兜铃酸 I 在大鼠、小鼠和人体内肾脏 DNA 加合物形成的体内剂量反应曲线。
J Appl Toxicol. 2020 Dec;40(12):1647-1660. doi: 10.1002/jat.4024. Epub 2020 Jul 7.